Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Nelson

Dermatology Gig Harbor, WA Medical Doctor

NPI 1093765034 CMS profile 276881

4700 Point Fosdick Dr Nw Ste 219, Gig Harbor, WA 98335

Open in the dashboard

General payments

$3,228

183 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Nelson of Gig Harbor, WA is reported in the CMS Open Payments database as having received $3,228 across 183 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 55th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $697 33
2024 General $903 39
2023 General $1,106 65
2022 General $218 20
2021 General $245 22
2020 General $37 2
2019 General $23 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Nelson
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Michael Nelson were reported at $697. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Michael Nelson Dermatology median Middle half National median
2019 $23 $454 $129–$1,240 $163
2020 $37 $235 $81–$756 $114
2021 $245 $377 $108–$1,108 $132
2022 $218 $514 $143–$1,391 $149
2023 $1,106 $607 $159–$1,674 $160
2024 $903 $751 $204–$1,903 $164
2025 $697 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Janssen Biotech, Inc. $1,039 53 payments
  2. AbbVie, Inc. $1,014 63 payments
  3. Sun Pharmaceutical Industries Inc. $245 12 payments
  4. Organon LLC $235 20 payments
  5. Pfizer Inc. $182 12 payments
  6. Novartis Pharmaceuticals Corporation $140 8 payments
  7. Pharming Healthcare, Inc. $126 1 payment
  8. Sanofi-Aventis U.S. LLC $72 1 payment
  9. Sientra, Inc. $37 2 payments
  10. BioWound Solutions, Inc. $31 3 payments
  11. Other $108 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,991 180 payments
  2. Education $237 3 payments
Products named General payments · program years 2019–2025
  1. TREMFYA $968 46 payments
  2. RINVOQ $750 35 payments
  3. SKYRIZI $258 27 payments
  4. HADLIMA $235 20 payments
  5. Winlevi $158 5 payments
  6. Absorica LD $137 3 payments
  7. RUCONEST $126 1 payment
  8. LITFULO $105 1 payment
  9. DUPIXENT $91 2 payments
  10. COSENTYX $86 5 payments
  11. Other $794 75 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 17 drugs

Part D claims

563

Median for Dermatology: 534

Drug cost

$117,348

Median for Dermatology: $67,151

Branded share of claims

4.4%

Median for Dermatology: 8.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cosentyx Sensoready (2 Pens) Secukinumab Brand 12 $103,161
Fluorouracil Generic 32 $2,421
Clobetasol Propionate Generic 44 $1,744
Triamcinolone Acetonide Generic 105 $1,453
Tretinoin Generic 12 $1,186
Azelaic Acid Generic 16 $1,170
Metronidazole Generic 34 $1,170
Ketoconazole Generic 100 $1,155
Minocycline Hcl Generic 47 $979
Fluocinonide Generic 18 $663

The 10 drugs with the highest cost, of 17 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 51 billing codes

Paid by Medicare

$143,483

Medicare's payments for the services billed

Medicare patients

760

Average age 76

Services billed

3,724

356 women, 404 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 63%
Arthritis 41%
Ischemic heart disease 20%
Diabetes 18%
Chronic kidney disease 17%
Atrial fibrillation 16%
Cancer 15%
Osteoporosis 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 7 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
RINVOQ
  • AbbVie, Inc. $394
$394 — —
TREMFYA
  • Janssen Biotech, Inc. $223
$223 — —
HADLIMA
  • Organon LLC $145
$145 — —
SKYRIZI
  • AbbVie, Inc. $49
$49 — —
Otezla
  • Amgen Inc. $29
$29 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 7 in the dashboard with a free account

Records

183 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record